BREYANZI is a prescription medicine used to treat large B cell lymphoma, a type of non-Hodgkin lymphoma, when:

  • your first treatment has not worked or your cancer returned within a year of your first treatment OR...Read more

This website is best viewed using the horizontal display on your tablet device.

This website is best viewed using the vertical display on your mobile device.

Powered to find and fight lymphoma

Breyanzi® is created specifically for you, starting with your own T cells

T cells T cells

T cells

  • Your immune system is made up of many cells that help protect the body from disease, including cancer

  • One key immune cell is the T cell

  • T cells have hooks on the surface (called receptors) that can attach to some cancer cells and help destroy them. Some types of cancer can avoid T cells and keep growing

How Breyanzi is made

CAR plus T cell equals Breyanzi® (lisocabtagene maraleucel) CAR T cell CAR plus T cell equals Breyanzi® (lisocabtagene maraleucel) CAR T cell

CAR

The new receptors that are added to the
T cells

T cells

A type of cell in your immune system

Breyanzi CAR T cells

CARs added onto your T cells. These cells are powered to find and fight lymphoma

Breyanzi® (lisocabtagene maraleucel) CAR T cell and lymphoma cell

How Breyanzi works in your body

  • Once the Breyanzi CAR T cells are made, they’ll be put back into your body through an infusion

  • After the infusion, the CAR T cells look for a marker found on certain cancer cells, as well as on some healthy cells

  • Breyanzi attaches to the marker on lymphoma cells that allows Breyanzi and your body to find and fight cancer

See Breyanzi treatment outcomes.

LEARN MORE